1. Qiao, Xinran, Lin, Jingyu, Shen, Jiajia, Li, Pengyu, Wang, Zhen. 2023. FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation. In Oncogene, 42, 2878-2891. doi:10.1038/s41388-023-02809-0. https://pubmed.ncbi.nlm.nih.gov/37596321/
2. Cassina, Matteo, Rigon, Chiara, Casarin, Alberto, Salviati, Leonardo, Clementi, Maurizio. 2015. FBXO28 is a critical gene of the 1q41q42 microdeletion syndrome. In American journal of medical genetics. Part A, 167, 1418-20. doi:10.1002/ajmg.a.37033. https://pubmed.ncbi.nlm.nih.gov/25900767/
3. Schneider, Amy L, Myers, Candace T, Muir, Alison M, Mefford, Heather C, Scheffer, Ingrid E. 2020. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability. In Epilepsia, 62, e13-e21. doi:10.1111/epi.16784. https://pubmed.ncbi.nlm.nih.gov/33280099/
4. Kratz, Anne-Sophie, Richter, Kai T, Schlosser, Yvonne T, Delecluse, Henri-Jacques, Hoffmann, Ingrid. 2016. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation. In Cell cycle (Georgetown, Tex.), 15, 3419-3431. doi:10.1080/15384101.2016.1246093. https://pubmed.ncbi.nlm.nih.gov/27754753/
5. Phillips, Emma, Balss, Jörg, Bethke, Frederic, Fendt, Sarah-Maria, Goidts, Violaine. 2022. PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. In Oncogenesis, 11, 57. doi:10.1038/s41389-022-00433-3. https://pubmed.ncbi.nlm.nih.gov/36115843/
智鼠故事 
